ConductScience.org, home

Paper33762015

Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives.

Alves ALV and 7 others. Stem Cell Res Ther, 2021. Cited by 153 papers, by iCite.

Cite this record

ConductScience Library. Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives. Papers, record 33762015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33762015

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives.
PubMed
Journal
Stem Cell Res Ther
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
153
iCite
Relative citation ratio, by iCite
9.97
iCite
Revised in PubMed
2021-07-08
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alves ALVAna Laura V
2Gomes INFIzabela N F
3Carloni ACAdriana C
4Rosa MNMarcela N
5da Silva LSLuciane S
6Evangelista AFAdriane F
7Reis RMRui Manuel
8Silva VAOViviane Aline O

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Brain NeoplasmsMajor topic
GlioblastomaMajor topic
Cell Line, Tumor
Drug Resistance, Neoplasm
Humans
Neoplastic Stem Cells

Source PubMed

Download CSV of topics

References224

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130356138State-of-the-art strategies for targeting the DNA damage response in cancer.Nat Rev Clin Oncol2019https://conductscience.org/library/papers/30356138PubMed
217317837Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.Clin Cancer Res2007https://conductscience.org/library/papers/17317837PubMed
317051156Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.Nature2006https://conductscience.org/library/papers/17051156PubMed
431555593New Insights Into Implementation of Mesenchymal Stem Cells in Cancer Therapy: Prospects for Anti-angiogenesis Treatment.Front Oncol2019https://conductscience.org/library/papers/31555593PubMed
524311635The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.Neuro Oncol2014https://conductscience.org/library/papers/24311635PubMed
625522764Radiotherapy followed by aurora kinase inhibition targets tumor-propagating cells in human glioblastoma.Mol Cancer Ther2015https://conductscience.org/library/papers/25522764PubMed
719671863CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.Clin Cancer Res2009https://conductscience.org/library/papers/19671863PubMed
830371825PubChem 2019 update: improved access to chemical data.Nucleic Acids Res2019https://conductscience.org/library/papers/30371825PubMed
928076755RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells.Stem Cell Reports2017https://conductscience.org/library/papers/28076755PubMed
1029423098Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome.Oncotarget2018https://conductscience.org/library/papers/29423098PubMed
1118215105Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.PLoS Med2008https://conductscience.org/library/papers/18215105PubMed
1223594862Targeting cancer stem cells for treatment of glioblastoma multiforme.Cell Transplant2013https://conductscience.org/library/papers/23594862PubMed
1311545254Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells.Cell Tissue Res2001https://conductscience.org/library/papers/11545254PubMed
1429069805Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance.Oncotarget2017https://conductscience.org/library/papers/29069805PubMed
1531277291A Comprehensive Review of Autophagy and Its Various Roles in Infectious, Non-Infectious, and Lifestyle Diseases: Current Knowledge and Prospects for Disease Prevention, Novel Drug Design, and Therapy.Cells2019https://conductscience.org/library/papers/31277291PubMed
1621108935Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy.Brain Res2011https://conductscience.org/library/papers/21108935PubMed
1720472883mTOR signaling in glioblastoma: lessons learned from bench to bedside.Neuro Oncol2010https://conductscience.org/library/papers/20472883PubMed
1826830677Targeting autophagy to sensitive glioma to temozolomide treatment.J Exp Clin Cancer Res2016https://conductscience.org/library/papers/26830677PubMed
1920530703Drugs that target the stemness pathways.Clin Cancer Res2010https://conductscience.org/library/papers/20530703PubMed
2028693199Epidermal growth factor receptor in glioblastoma.Oncol Lett2017https://conductscience.org/library/papers/28693199PubMed

See all 224 referencesDownload CSV of references

Cited by116

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.

PMIDTitleJournalYearIn PapersSource
42558850Glioblastoma stem cells as carriers of tumour memory: a strategy for personalised immunotherapy using tumour-infiltrating lymphocytes.Front Immunol2026https://conductscience.org/library/papers/42558850PubMed
42548479Modern brachytherapy in glioblastoma: overcoming clinical barriers to improve local control.Front Oncol2026https://conductscience.org/library/papers/42548479PubMed
42542877The suppressor of cytokine signaling 3 regulates glioma stem cell maintenance and immune microenvironment through signal transducer and activator of transcription 3 signaling.J Cell Commun Signal2026https://conductscience.org/library/papers/42542877PubMed
42491242Reconstructing the glioblastoma microenvironment in heterotypic 3D spheroids: a multicellular model to study tumor-stromal crosstalk.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42491242PubMed
42252341Temozolomide and ruxolitinib combination modulates miRNA-associated regulatory networks in glioblastoma stem cells.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42252341PubMed
42151414Computational design and immunoinformatics validation of a T cell multi-epitope vaccine targeting glioblastoma stem cells.Sci Rep2026https://conductscience.org/library/papers/42151414PubMed
42084925Development and characterization of triazole-based WDR5 inhibitors for the treatment of glioblastoma.JCI Insight2026https://conductscience.org/library/papers/42084925PubMed
42017986Interactions and communications in the glioblastoma microenvironment: potential targets for chemo-/radiotherapy.Strahlenther Onkol2026https://conductscience.org/library/papers/42017986PubMed
41957020Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs.Nat Commun2026https://conductscience.org/library/papers/41957020PubMed
41951696Effects of CRISPR-Cas9-mediated CEP55 gene knockout on immune evasion mechanisms of liver cancer cells.Sci Rep2026https://conductscience.org/library/papers/41951696PubMed
41930350The Nexus of Stemness, Telomere Stability, and Metabolic Reprogramming in Glioblastoma: Foundations of Tumor Persistence and Targets for Intervention.MedComm (2020)2026https://conductscience.org/library/papers/41930350PubMed
41913047Exploring the immune environment of glioblastoma in humanized mouse models.Neuro Oncol2026https://conductscience.org/library/papers/41913047PubMed
41828436Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.Int J Mol Sci2026https://conductscience.org/library/papers/41828436PubMed
41827793Translating Molecular Insights into Effective Targeting of Glioblastoma Stem Cells.Cancers (Basel)2026https://conductscience.org/library/papers/41827793PubMed
41789657Cellular and inflammatory characteristics of patient‑derived glioblastoma organoids during in vitro cultivation.Oncol Rep2026https://conductscience.org/library/papers/41789657PubMed
41684714Innovative radiotherapies for the treatment of glioblastoma.Neurooncol Adv2026https://conductscience.org/library/papers/41684714PubMed
41615212Overcoming Intrinsic and Acquired Temozolomide Resistance in Glioblastoma: Fisetin as a Potential Strategy to Enhance Sensitivity via ZEB1 Modulation.Turk J Pharm Sci2026https://conductscience.org/library/papers/41615212PubMed
41574218Mesoporous silica nanoparticles in glioblastoma: smart nano-platforms for targeted therapy and precision diagnosis.3 Biotech2026https://conductscience.org/library/papers/41574218PubMed
41556041Inhibition of FOS-Like Antigen 1 Reduces Chemoresistance to Temozolomide Through Stemness Reprogramming via IL-6/STAT3Tyr705 Pathway.MedComm (2020)2026https://conductscience.org/library/papers/41556041PubMed
41471318Bioengineering Stem Cell-Derived Glioblastoma Organoids: A Comprehensive Review.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41471318PubMed

See all 116 cited byDownload CSV of cited by

Genes69

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCC14363PubTator's text mininghttps://conductscience.org/library/genes/4363NCBI Gene
ABCG29429PubTator's text mininghttps://conductscience.org/library/genes/9429NCBI Gene
ACACA31PubTator's text mininghttps://conductscience.org/library/genes/31NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALDH1A1216PubTator's text mininghttps://conductscience.org/library/genes/216NCBI Gene
ALOX5240PubTator's text mininghttps://conductscience.org/library/genes/240NCBI Gene
ATG59474PubTator's text mininghttps://conductscience.org/library/genes/9474NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
ATR545PubTator's text mininghttps://conductscience.org/library/genes/545NCBI Gene
ATRX546PubTator's text mininghttps://conductscience.org/library/genes/546NCBI Gene
AURKA6790PubTator's text mininghttps://conductscience.org/library/genes/6790NCBI Gene
BECN18678PubTator's text mininghttps://conductscience.org/library/genes/8678NCBI Gene
BMP1649PubTator's text mininghttps://conductscience.org/library/genes/649NCBI Gene
BMP2650PubTator's text mininghttps://conductscience.org/library/genes/650NCBI Gene
BMP4652PubTator's text mininghttps://conductscience.org/library/genes/652NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
CDKN1A1026PubTator's text mininghttps://conductscience.org/library/genes/1026NCBI Gene

See all 69 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33762015

GET https://conductscience.org/api/papers/v1/33762015/references?page=2